Harvons (002900)
Overview
Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale chemical pharmaceutical preparations in China. The company offers various drugs for nervous system, cardiovascular system, systemic anti-infective, muscle and skeletal system, nutritional infusion, and body fluid balance infusion; and other products, including oxaliplatin for injection, calcium folinate for injection, hydroxylcamptothecine injection, tropisetron hydrochloride for injection, tropise
Market Cap$3.2B
Revenue$813.2M
Listed OnShenzhen Stock Exchange
Ticker002900
CEOMr. Jian Fei Qin
HeadquartersHarbin